minoxidil / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   54 Trials   54 Trials   1767 News 
67 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
minoxidil / Generic mfg.
2005-005418-19: Comparison of the efficiency between Minoxidil 5% or Finasteride 1mg and Minoxidil 5% + Finasteride 1mg in androgenetic alopecia (male pattern) at Hamilton classification scale II - V.

Ongoing
4
60
Europe
Finsteride, Minoxidil, Propecia, 5% - Minoxidil - Lösung, Propecia, 5% - Minoxidil - Lösung
Dr. med. Bernd Salzer, Private Praxis
Alopecia androgenetica
 
 
2008-001705-42: ETUDE TRANSCRIPTOMIQUE DE LA REPONSE AU MINOXIDIL CHEZ L\'HOMME ALOPECIQUE

Ongoing
4
16
Europe
minoxidil 5%, minoxidil 5%
L\'OREAL
alopécie androgénétique
 
 
ChiCTR2200058578: Study on the relationship between the curative effect of 5% minoxidil tincture in the treatment of prepubertal atrophy of androgenetic alopecia

Recruiting
4
100
 
None
The Second Affiliated Hospital of Zhejiang University School of Medicine; The Second Affiliated Hospital of Zhejiang University School of Medicine, National Natural Science Foundation of China
Androgenic alopecia
 
 
NCT06043349: Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

Active, not recruiting
4
36
RoW
Platelet-Rich Plasma and Topical 5% Minoxidil, Topical 5% Minoxidil
Indonesia University
Androgenetic Alopecia
09/23
09/23
CCCA, NCT04207931: Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (): a Multicenter Prospective Study

Recruiting
4
250
US
Topical steroid class I-II, Clobetasol, Betamethasone Dipropionate, or Fluocinonide, Triamcinolone Acetonide, Kenaolog, Doxycyline, Doxy-100, Targadox, Oracea, Minoxidil, Rogaine
Wake Forest University Health Sciences, The Skin of Color Society
Central Centrifugal Cicatricial Alopecia (CCCA)
10/25
01/26
MTWH-RCT, NCT06813963: Minoxidil for Treating White Hair: a Randomized Controlled Trial

Not yet recruiting
4
100
NA
Topical Minoxidil(5%) to the scalp., 2%minoxidil group, Placebo
Southern Medical University, China
Grey Hair
02/25
02/25
ChiCTR2400090249: A prospective, multicenter, real-world study of minoxidil liniment in the treatment of androgenic alopecia

Recruiting
4
10000
 
None. ; None.
China-Japan Friendship Hospital; China-Japan Friendship Hospital, Horizontal project (sponsor: Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.)
androgenic alopecia
 
 
NCT05989165: Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

Completed
3
36
RoW
Minoxidil 5% Topical Solution, microneedling
Indonesia University
Androgenetic Alopecia
09/23
09/23
NCT05888922: Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Not yet recruiting
3
520
NA
Minoxidil Tablets, Minoxidil Topical, Placebo oral tablet, Vehicle solution
Industrial Farmacéutica Cantabria, S.A., Bioskin GmbH, BioClever 2005 S.L.
Androgenetic Alopecia, Female Pattern Baldness
06/25
10/25
NCT06484881: Clinical Study of Probiotic Treatment for Androgenetic Alopecia

Withdrawn
3
322
NA
Daniel Alain Probiotic Treatment for Androgenetic Alopecia, Topical minoxidil 5%
Applied Biology, Inc., Follea International Limited
Androgenetic Alopecia, Female Pattern Baldness
10/24
10/24
MINOX, NCT04721548: Treatment of Androgenetic Alopecia in Men for 24 Weeks

Completed
3
336
RoW
Minoxidil Topical Foam, Placebo
Eurofarma Laboratorios S.A.
Alopecia
03/24
03/24
ChiCTR2300077296: Efficacy of 2% concentration of topical minoxidil tincture combined with micronedles in the treatment of androgenic alopecia areata (AGA) in Chinese adult women: a single-center, randomized, open-controlled clinical trial

Not yet recruiting
3
234
 
2% minoxidil tincture twice daily, dosage of 1ml each time for 24 weeks; 2% minoxidil tincture 1ml bid combined with microneedle q2w for 24weeks; 2% minoxidil tincture 1ml bid combined with microneedle q4w for 24weeks
Dermatology Hospital of Southern Medical University; Dermatology Hospital of Southern Medical University, Clinical Research Project of Shanxi Zhendong Pharmaceutical Co., LTD. (ZD-ZY-HX-20221012001)
Androgenic alopecia
 
 
NCT06501924: Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Not yet recruiting
3
516
NA
DA-005, Daniel Alain Botanical Supplement Treatment for Hair Loss, Topical minoxidil 5%, DA-002, Placebo Oral Tablet, Placebo Topical Solution
Applied Biology, Inc., Follea International Limited, Daniel Alain, Inc.
Androgenetic Alopecia, Female Pattern Baldness, Male Pattern Baldness
10/25
12/25
NCT04594018: Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

Recruiting
3
190
RoW
Finlândia Association + finasteride placebo, Minoxidil + finasteride
EMS
Androgenetic Alopecia
04/25
09/25
NCT04481412: Topical Cetirizine in Androgenetic Alopecia in Females

Completed
2/3
66
RoW
Topical cetirizine, Cetirizine 1%, Placebo, 96% ethanol, Topical minoxidil, Minoxidil 5%
Cairo University
Androgenetic Alopecia
11/21
11/21
NCT05990400: Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia

Recruiting
2/3
40
RoW
Finasteride, Minoxidil
Indonesia University
Androgenetic Alopecia
10/23
12/23
2006-005745-11: Efficacité du minoxidil chez les enfants atteints du syndrome de Williams et Beuren : un essai clinique randomisé

Ongoing
2
11
Europe
LONOTEN, LONOTEN
Hospices Civils de Lyon
Williams syndrome
 
 
2017-000613-22: A 16 week study to assess the effectiveness of two minoxidil formulations in humans with hereditary hair loss

Ongoing
2
140
Europe
5% Minoxidil Topical Gel, 5% Minoxidil Topical Foam, F13496-121, Gel, Cutaneous foam, Regaine 5 % Schaum zur Anwendung auf der Kopfhaut
Johnson & Johnson Consumer Inc, Johnson & Johnson Consumer Inc
Alopecia Androgentica, Hereditary hair loss, Body processes [G] - Physiological processes [G07]
 
 
2019-000950-78: Multi center clinical study to evaluate the safety and efficacy of CB-03-01 for the treatment of female pattern hair loss, versus Minoxidil and placebo at different dosage of CB-03-01

Not yet recruiting
2
280
Europe
Cortexolone 17α-propionate solution 5%, Cortexolone 17α-propionate solution 7.5%, CB-03-01 solution 5%, CB-03-01 solution 7.5%, Cutaneous solution, Regaine® Frauen
Cassiopea S.p.A., Cassiopea S.p.A.
Female Androgenic Alopecia (AGA) is scalp hair loss that occurs due to an underlying susceptibility of hair follicles to androgenic miniaturization. In the hair follicle, testosterone is converted by 5α-reductase into 5α-dihydrotestosterone (DHT). The DHT level is increased in the balding scalp and may be the more relevant androgen for AGA pathogenesis. Thus, blocking or inhibiting the effect of DHT with the local application of Anti-androgens may be an effective treatment for AGA., Female Androgenetic alopecia (AGA) is scalp hair loss which is due to a change in hormon concentrations which results in reduced hair growth and hair loss., Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
NCT03852992: Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

Withdrawn
2
48
US
Post-Laser Minoxidil 2%, Rogaine, At-Home Minoxidil 5%, Laser, Post-laser 5mg minoxidil, Post-laser 10mg minoxidil, Post-laser 20mg minoxidil
University of Minnesota
Male Pattern Hair Loss, Androgenetic Alopecia, Male Pattern Baldness
07/23
07/23
NCT05272462: Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

Recruiting
2
34
US
Minoxidil, Rogaine
Loyola University, Cures Within Reach, Medical University of South Carolina
Ovarian Cancer
12/24
12/24
NCT06826001: Various Procedural Treatment Options for Androgenetic Alopecia

Not yet recruiting
2
190
RoW
topical finasteride, Topical minoxidil
Sheikh Zayed Medical College
Androgenetic Alopecia
07/25
07/25
NCT05778825: A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Recruiting
2
60
US
Oral Minoxidil, Placebo
Memorial Sloan Kettering Cancer Center
Survivors of Childhood Cancer, Alopecia
03/26
03/26
NCT06333600: Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss

Recruiting
1/2
45
RoW
Topical minoxidil, Rogaine, Topical Vitamin D, Calcipotriol, Saline spray, saline
Sohag University
Dermatology, Female Pattern Baldness
04/24
05/24
NCT06108193: Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris

Recruiting
1/2
26
RoW
topical minoxidil in Acne Vulgaris
Chang Gung Memorial Hospital
Acne Vulgaris
12/23
12/23
NCT05636904: Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men

Completed
1/2
120
RoW
prostaglandin F2a analogue in vehicle solution high dose, DLQ01 high dose, prostaglandin F2a analogue in vehicle solution low dose, DLQ01 low dose, active ingredient-free vehicle solution to DLQ01, DLQ01 vehicle, Minoxidil 5% Topical Solution, Regaine®
Dermaliq Therapeutics, Inc.
Androgenetic Alopecia
03/24
03/24
NCT06527729: A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata

Completed
1
28
RoW
sildenafil-loaded liposomes, minoxidil gel
Assiut University
Alopecia Areata
06/22
10/22
NCT05790941: Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation

Recruiting
1
12
US
Latanoprost and Minoxidil
Aneira Pharma, Inc.
Hypotrichosis
06/23
06/23
NCT05864885: Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia

Not yet recruiting
1
14
NA
Minoxidil, Latanoprost
Aneira Pharma, Inc., DataPharm Australia, CMAX Clinical Research, Agilex Australia
Androgenetic Alopecia
07/23
07/23
NCT03831334: Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

Active, not recruiting
1
14
US
oral minoxidil
Northwestern University
Permanent Chemotherapy-induced Alopecia
06/24
06/24
NCT06015516: Bioavailability Clinical Trial of Oral Minoxidil 1 mg

Completed
1
14
Europe
Minoxidil Tablets, Minoxidil topical solution 20 mg/ml
Industrial Farmacéutica Cantabria, S.A.
Healthy
03/24
03/24
NCT05417308: Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Recruiting
1
50
US
Minoxidil, Alostil, Loniten, Rogaine, U 10858, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Ohio State University Comprehensive Cancer Center
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Endocrine Therapy-Induced Alopecia, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
12/25
12/25
ACTRN12623000356662: The effect of sublingual minoxidil and oral dutasteride in trans people with androgenic alopecia while on testosterone

Active, not recruiting
1
32
 
The University of Melbourne, The University of Melbourne
Androgenic alopecia
 
 
NCT06679556: Phase 1 Pharmacokinetic Study of Minoxidil SL Tablets

Completed
1
12
RoW
Strength A Sublingual Minoxidil, Strength B Sublingual Minoxidil
Samson Clinical Operations Pty Ltd
Pharmacokinetic
12/24
12/24
ChiCTR1900021107: Combined treatment with topical minoxidil and nano-microneedle-assisted fibroblast growth factor in male androgenetic alopecia

Completed
N/A
40
 
nano-microneedle combined with saline ;topical 5% minoxidil ;nano-microneedle combined with fibroblast growth factor ;combined treatment with topical minoxidil and nano-microneedle-assisted fibroblast growth factor
First Hospital of China Medical University; First Hospital of China Medical University, International Science and Technology Cooperation Project Cooperative Study on the Mechanism of Dot Laser Combined with KGF-2 Promoting Hair Growth
male androgenic alopecia
 
 
ChiCTR2000030161: Treatment of androgenic alopecia in males with autologous concentrate growth factor combined with minoxidil: a randomized self-controlled trial

Completed
N/A
16
 
local injection of autologous concentrate growth factor combined with minoxidil for external use in half head
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine; Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, funds raised independently
Androgenic alopecia in males
 
 
ChiCTR1900022122: Efficacy and safety of 2% minoxidil combined with microneedling in the treatment of female pattern hair loss: a randomized controlled trial

Recruiting
N/A
338
 
Topical 2% minoxidil combined with microneedling ;Topical 2% minoxidil
Huashan Hospital, Fudan University; Huashan Hospital, Fudan University, Huashan Hospital, Fudan University
Female pattern hair loss
 
 
ChiCTR1900023751: Efficacy and safety of 5% minoxidil combined with microneedling in the treatment of alopecia areata of stable period: a randomized controlled trial

Recruiting
N/A
100
 
Left scalp: 5% minoxidil combined with microneedling; Right scalp: 5% minoxidil ;Right scalp: 5% minoxidil combined with microneedling; Left scalp: 5% minoxidil
Huashan Hospital, Fudan University; Huashan Hospital, Fudan University, Huashan Hospital, Fudan University
Alopecia areata
 
 
ChiCTR2000038833: Clinical trial of effect on androgenic alopecia treated with decoction of Garden Balsam and Platycladus orientalis leaves

Recruiting
N/A
180
 
Decoction of Garden Balsam and Platycladus orientalis leaves (3-5ml each time), evenly spread on the head, and massage with hands for 3-5 minutes, twice a day. ;Decoction of Garden Balsam and Platycladus orientalis leaves (3-5ml each time), evenly spread on the head, and massage with hands for 3-5 minutes, twice a day.Oral decoction of Garden Balsam and Platycladus orientalis leaves (100ml each time), half an hour after meal, twice a day. ;Apply 5% minoxidil tincture (National drug approval number: h20010714), 1ml each time (about 7 sprays) on head, and massage with hands for 3-5 minutes, twice a day.
Jiaxing Hospital of Chinese Medicine; Jiaxing Hospital of Chinese Medicine, Project of science and technology of Chinese medicine in Zhejiang Province
Androgenic alopecia
 
 
ChiCTR1800019282: A randomized, open label, parallel controlled trial for botulinum toxin A injection combined with minoxidil in the treatment of androgenic alopecia

Not yet recruiting
N/A
75
 
Minoxidil group for external use; botulinum toxin A injection group ;Topical minoxidil combined with injection of botulinum toxin type A
Shanghai Tongji Hospital; Shanghai Tongji Hospital, The project of self selection
Androgenetic alopecia
 
 
ChiCTR2100044015: Comparative study on treatment methods of female pattern hair loss

Completed
N/A
135
 
Minoxidil solution ;Minoxidil solution and spironolactone ;Minoxidil and laser hair cap ;Minoxidil and microneedle ;YuFa and microneedle
Beijing Friendship Hospital affiliated to Capital Medical University; Beijing Friendship Hospital affiliated to Capital Medical University, self-financing
female pattern hair loss
 
 
ChiCTR2000029451: A randomized, open label, parallel-controlled trial for CO2 fraction laser combined with topical minoxidil in the treatment of androgenic alopecia

Not yet recruiting
N/A
60
 
The hair loss area was treated by Co2 dot-matrix laser irradiation once, pulse energy 10 MJ, dot-matrix coverage 6.3% . After treatment, the hair was iced for 15 min, local water was avoided within 12 H, and antibiotic ointment was applied, once a month for 12 months. 5% MINOXIDIL was given oral ;The hair loss area was treated by Co2 dot-matrix laser irradiation once, pulse energy 10 MJ, dot-matrix coverage 6.3% . After treatment, the hair was iced for 15 min, local water was avoided within 12 H, and antibiotic ointment was applied, once a month for 12 months. ;Local hair loss area for external use Minoxidil, once a day, for a year.
Shanghai tongji hospital; Shanghai Tongji hospital, none
androgenic alopecia
 
 
ChiCTR2000032671: A prospective randomized controlled study on the treatment of Female Androgenic Alopecia with cell-free fat extract

Not yet recruiting
N/A
24
 
Cell-free extract injection ;Minoxidil for external use
The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine; Affiliated Hangzhou First people's Hospital, Zhejiang University School of Medicine, Horizontal project of the Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Female Androgenic Alopecia
 
 
ChiCTR2000033207: Randomized, open, parallel controlled clinical study of Haiai Decoction combined with oral administration of finasteride for male androgenic alopecia

Not yet recruiting
N/A
90
 
Oral Finasteride 1mg / D + external water shampoo ;Oral Finasteride 1mg / D + Haiai Decoction for external use ;Oral Finasteride 1mg / D + topical 5% Minoxidil
Shanghai Tongji Hospital; Shanghai Tongji Hospital, nothing
androgenic alopecia
 
 
NCT05369481: Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia

Recruiting
N/A
50
RoW
Sildenafil 2%, Local Scalp Injection, Minoxidil 5 %
Mohammed Abd El Mawgoud Amer
Androgenic Alopecia
08/22
09/22
NCT05435625: Fractional Laser Versus Radiofrequency in Androgenetic Alopecia

Recruiting
N/A
30
RoW
FCO2, FRF
Kasr El Aini Hospital
Androgenic Alopecia
09/22
12/22
ChiCTR2100051480: Clinical trial to evaluate the safety and efficacy of ablative fractional CO2 laser in the treatment of mild to moderate alopecia areata in Chinese adults

Recruiting
N/A
30
 
minoxidil solution treatment of treatment of alopecia areata ;ablative fractional CO2 laser treatment of alopecia areata
Dermatology Hospital of Southern Medical University; Dermatology Hospital of Southern Medical University, self-raised
alopecia areata
 
 
NCT05681897: Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia

Recruiting
N/A
30
RoW
Platelet-Rich Plasma Injections (PRP) on the Scalp, Regrou Forte (5% Minoxidil solution)
Indonesia University
Alopecia, Androgenetic
02/23
02/23
ChiCTR2000034976: A randomized, open label, placebo-controlled trial for platelet-rich plasma(PRP) combined with topical 5% minoxidil in the treatment of male androgenic alopecia

Not yet recruiting
N/A
30
 
5% minoxidil solution, 1ml for external application each time,twice a day for 6 months. On this basis, it is combined with local injection of PRP, 0.15 ml/cm2 each time, monthly, 3 times totally. ;5% minoxidil solution, 1ml for external application each time, twice a day for 6 months. On this basis, it is combined with local injection of 0.9% normal saline, 0.15 ml/cm2 each time, monthly, 3 times totally.
Shanghai Tongji Hospital; Shanghai Tongji hospital, None
Androgenic alopecia
 
 
ChiCTR2200064992: A prospective randomized controlled study on the treatment of female pattern hair loss with cell-free fat extract

Not yet recruiting
N/A
24
 
Cell-free extract injection ;5% Minoxidil for external use
Hangzhou First People's Hospital; Hangzhou First People's Hospital, Shanghai Samet Cell Technology Co. LTD
female pattern hair loss
 
 
NCT06218498: Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia

Recruiting
N/A
135
RoW
ablative fractional 2940-nm Er: YAG laser, non-ablative fractional 1565nm, 5% Minoxidil
Second Affiliated Hospital, School of Medicine, Zhejiang University
Androgenetic Alopecia
06/24
12/24
NCT06066827: Hair Regeneration in Androgenetic Alopecia

Active, not recruiting
N/A
60
RoW
Minoxidil Topical, Secretome from adipose-derived stem cells, Combination of minoxidil and secretome from adipose-derived stem cells
Dr. dr. Lili Legiawati, SpKK(K), Ministry of Education, Culture, Research, and Technology, Republic of Indonesia, PT. Kimia Farma (Persero) Tbk
Androgenetic Alopecia
11/23
11/23
NCT06218394: Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia

Recruiting
N/A
135
RoW
microneedling, Autologous Concentrated Growth Factor, 5% minoxidil
Second Affiliated Hospital, School of Medicine, Zhejiang University
Androgenetic Alopecia
09/24
12/24
NCT05827991: A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia

Recruiting
N/A
75
RoW
1565nm Non-ablative Fractional Laser, 5% minoxidil external use, 1565nm Non-ablative Fractional Laser combined with 5% minoxidil
Xijing Hospital
Androgenic Alopecia
12/23
12/23
NCT05587257: Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata

Not yet recruiting
N/A
60
NA
Fractional CO2 laser, Drug, Derma pen, Niosome minoxidil, Minoxidil Topical Spray
Assiut University
Alopecia Areata
01/24
02/24
NCT06552039: Proof-of-Science, Prospective, Interventional, Three-arm, Double-Blind, Randomized, Safety and Efficacy Real World Evidence Study.

Not yet recruiting
N/A
99
NA
Polyherbal Hair Oil, Minoxidil Herbal Hair Oil + Minoxidil 5 (%) Hair Serum, Minoxidil Hair Serum
NovoBliss Research Pvt Ltd
Hair Fall and Pre-mature Graying
12/24
12/24
NCT06556056: An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)

Not yet recruiting
N/A
54
NA
SesZen-Bio Serum, Minoxidil hair serum (1%), Placebo
NovoBliss Research Pvt Ltd, Zywie Ventures Privated Ltd
Androgenic Alopecia
03/25
03/25
ChiCTR2300077392: Clinical efficacy and safety of microneedles with nitric oxide source complex solution in the treatment of non-menopausal female pattern hair loss

Completed
N/A
120
 
microneedles combined with nitric oxide source complex solution; simple topical minoxidil solution; microneedles combined with minoxidil solution
Beijing Friendship Hospital, Capital Medical University; Beijing Friendship Hospital, Capital Medical University, self-financed
female pattern hair loss
 
 
ChiCTR2400085181: Clinical Efficacy and Safety Study of Recombinant Humanized Collagen XVII in the Treatment of Androgenetic Alopecia

Not yet recruiting
N/A
110
 
Apply 0.9% sodium chloride solution topically once daily for a total of 24 weeks.; For women, apply 1 ml of 5% Minoxidil Tincture topically once daily for a total of 24 weeks; for men, apply 1 ml of 5% Minoxidil Tincture topically twice daily for a total of 24 weeks; Apply one vial of recombinant type XVII collagen lyophilized fiber topically once daily for a total of 24 weeks; Perform microneedling combined with topical application of one vial of recombinant humanized type XVII collagen lyophilized fiber once every two weeks for a total of 24 weeks.
Beijing Friendship Hospital, Capital Medical University; Beijing Friendship Hospital, Capital Medical University, self-financed
Androgenetic Alopecia
 
 
ChiCTR2300071986: A single-center, randomized, single-blind, minoxidil controlled clinical efficacy study of concentrated nano fat in the treatment of androgenetic alopecia

Not yet recruiting
N/A
98
 
nano-fat treatment ;minoxidil treatment
The first affiliated hospital of Jinan University; The first affiliated hospital of Jinan University, NA
Androgenetic alopecia
 
 
ChiCTR2500099246: Efficacy and safety of magnesium alloy-based long-acting hydrogen-releasing ointment in the treatment of male pattern androgenic alopecia

Not yet recruiting
N/A
10
 
Participants applied 5% minoxidil tincture spray twice daily, morning and evening, administering the solution evenly across the observed area.; Apply the ointment twice daily, morning and evening, using 2 grams of Ointment A and 2 grams of Ointment B. Ensure thorough mixing before application and spread evenly over the test area.
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Ninth People's Hospital, Self-funded research project
Male androgen alopecia
 
 
ChiCTR2500096253: Effect of 5% minoxidil foam in combination with spironolactone in the treatment of female pattern hair loss

Not yet recruiting
N/A
80
 
NA; NA
Xiangya Hospital, Central South University; Xiangya Hospital Central South University, Researcher Project funding
female pattern hair loss
 
 
ChiCTR2300070840: Efficacy and safety of carbon dioxide fractional laser combined with minoxidil in the treatment of androgenetic alopecia

Not yet recruiting
N/A
178
 
Minoxidil combined with carbon dioxide fractional laser ;Minoxidil
Tongji Hospital Affiliated to Tongji University; Tongji Hospital Affiliated to Tongji University, Shanghai Municipal Health Commission
androgenetic alopecia
 
 
ChiCTR2400086751: A preliminary study on the characterization of hair microscopic analysis and prevention and treatment strategies after chemotherapy.

Not yet recruiting
N/A
100
 
Topical application of 5% minoxidil 1 ml topically once a day, plus 20 minutes of light once every two days using a low level laser cap.; Topical application of 5% minoxidil 1 ml topically once a day; Topical application of placebo 1 ml topically once a day; No treatment
Affiliated Hospital of Yanbian University; Affiliated Hospital of Yanbian University, Entrusted projects by enterprises and public institutions
Chemotherapy-induced alopecia
 
 
ChiCTR2300078123: Randomized controlled study of scalp acupoint catgut embedding combined with topical 5 % minoxidil tincture to improve male androgenetic alopecia

Recruiting
N/A
70
 
Basic treatment: According to the 2019 "Guidelines for the diagnosis and treatment of androgenetic alopecia in China", both groups of subjects were treated with 5 % minoxidil tincture for external use, once in the morning and once in the evening, 1ml each time, sprayed on the hair loss area on the top of the head. Embedding therapy: The subjects were placed in a prone position, and the top of the head was fully exposed. The target area was marked with a semi-permanent ornamentation method. After surgical disinfection in the circumferential area with a radius of 4cm centered on the marked point, 2 % lidocaine anesthesia was performed in the circumferential area with the marked point as the center and a radius of 2cm. The 1cm medical absorbable polyglycolic acid surgical suture was placed at the front end of the disposable embedding needle using the tweezers in the disposable embedding auxiliary package. The needle tip reached the subgaleal space at a depth of about 2-4mm. After the subjects had a sense of acid bloating, the needle core was pushed while the needle tube was withdrawn, and the thread body was placed in the space under the cap-like aponeurosis. The needle tip direction points outward from the anesthesia area to the eight directions of the circumference, east, west, south, north, southeast, southwest, northeast, and northwest. After the eight parts are treated, they are disinfected again.; Basic treatment: According to the 2019 "Guidelines for the diagnosis and treatment of androgenetic alopecia in China", both groups of subjects were treated with 5 % minoxidil tincture for external use, once in the morning and once in the evening, 1ml each time, sprayed on the hair loss area on the top of the head. Catgut embedding therapy: acupoint catgut embedding needle acupuncture treatment, disposable catgut embedding needle is not placed in the medical absorbable polyglycolic acid surgical suture, the rest of the operation method is the same as the acupoint catgut embedding group.
China-Japan Friendship Hospital; China-Japan Friendship Hospital, 1. National High Level Hospital Clinical Research Funding; 2. Elite Medical Professionals Project of China-Japan Friendship Hospital (NO.ZRJY2023-GG16)
androgenetic alopecia
 
 
ChiCTR2400088536: Clinical study of new polymer polylactic acid microneedle combined with 5% minoxidil application for the treatment of male androgenetic alopecia

Not yet recruiting
N/A
30
 
All study participants were sprayed with 1 ml of Minoxidil 5% application each time on the scalp area starting on day 1, applied evenly to all scalp areas, and the scalp was gently massaged with the hands until fully absorbed, ensuring that the scalp was completely dry before application. The medication is administered twice daily (morning and evening, bid). In addition, after the weekly medication, the patient should return to the hospital to receive the new polymer PLA micro-needling treatment, which is operated by the same medical team members who have been professionally trained. The method of operation: the patient maintains a comfortable seated position, and the right side of the scalp is fully exposed with the midline of the head as the boundary, the applicator will first disinfect the right side of the scalp with 75% alcohol twice, and then, when the alcohol is dry, the applicator will place strips in a row to disinfect the right scalp area, and then, the applicator will place the strips in a row. After the alcohol is dry in the scalp area, the needle applicator will gently prick the PLA microneedles arranged in strips to cover the scalp area of the hair seams once a week (qw) for 24 consecutive weeks of treatment.
China-Japan Friendship Hospital; China-Japan Friendship Hospital, Zhongshan Wanhan Pharmaceutical Co.
androgenetic alopecia
 
 
ACTRN12607000027415: Investigation into the treatment of Female Pattern Hair Loss

Not yet recruiting
N/A
150
 
Prof Rodney Sinclair, Head of Department of Dermatology, St Vincent's Hospital, Melbourne, NHMRC
Female Pattern Hair Loss
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
minoxidil / Generic mfg.
2005-005418-19: Comparison of the efficiency between Minoxidil 5% or Finasteride 1mg and Minoxidil 5% + Finasteride 1mg in androgenetic alopecia (male pattern) at Hamilton classification scale II - V.

Ongoing
4
60
Europe
Finsteride, Minoxidil, Propecia, 5% - Minoxidil - Lösung, Propecia, 5% - Minoxidil - Lösung
Dr. med. Bernd Salzer, Private Praxis
Alopecia androgenetica
 
 
2008-001705-42: ETUDE TRANSCRIPTOMIQUE DE LA REPONSE AU MINOXIDIL CHEZ L\'HOMME ALOPECIQUE

Ongoing
4
16
Europe
minoxidil 5%, minoxidil 5%
L\'OREAL
alopécie androgénétique
 
 
ChiCTR2200058578: Study on the relationship between the curative effect of 5% minoxidil tincture in the treatment of prepubertal atrophy of androgenetic alopecia

Recruiting
4
100
 
None
The Second Affiliated Hospital of Zhejiang University School of Medicine; The Second Affiliated Hospital of Zhejiang University School of Medicine, National Natural Science Foundation of China
Androgenic alopecia
 
 
NCT06043349: Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

Active, not recruiting
4
36
RoW
Platelet-Rich Plasma and Topical 5% Minoxidil, Topical 5% Minoxidil
Indonesia University
Androgenetic Alopecia
09/23
09/23
CCCA, NCT04207931: Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (): a Multicenter Prospective Study

Recruiting
4
250
US
Topical steroid class I-II, Clobetasol, Betamethasone Dipropionate, or Fluocinonide, Triamcinolone Acetonide, Kenaolog, Doxycyline, Doxy-100, Targadox, Oracea, Minoxidil, Rogaine
Wake Forest University Health Sciences, The Skin of Color Society
Central Centrifugal Cicatricial Alopecia (CCCA)
10/25
01/26
MTWH-RCT, NCT06813963: Minoxidil for Treating White Hair: a Randomized Controlled Trial

Not yet recruiting
4
100
NA
Topical Minoxidil(5%) to the scalp., 2%minoxidil group, Placebo
Southern Medical University, China
Grey Hair
02/25
02/25
ChiCTR2400090249: A prospective, multicenter, real-world study of minoxidil liniment in the treatment of androgenic alopecia

Recruiting
4
10000
 
None. ; None.
China-Japan Friendship Hospital; China-Japan Friendship Hospital, Horizontal project (sponsor: Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.)
androgenic alopecia
 
 
NCT05989165: Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

Completed
3
36
RoW
Minoxidil 5% Topical Solution, microneedling
Indonesia University
Androgenetic Alopecia
09/23
09/23
NCT05888922: Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Not yet recruiting
3
520
NA
Minoxidil Tablets, Minoxidil Topical, Placebo oral tablet, Vehicle solution
Industrial Farmacéutica Cantabria, S.A., Bioskin GmbH, BioClever 2005 S.L.
Androgenetic Alopecia, Female Pattern Baldness
06/25
10/25
NCT06484881: Clinical Study of Probiotic Treatment for Androgenetic Alopecia

Withdrawn
3
322
NA
Daniel Alain Probiotic Treatment for Androgenetic Alopecia, Topical minoxidil 5%
Applied Biology, Inc., Follea International Limited
Androgenetic Alopecia, Female Pattern Baldness
10/24
10/24
MINOX, NCT04721548: Treatment of Androgenetic Alopecia in Men for 24 Weeks

Completed
3
336
RoW
Minoxidil Topical Foam, Placebo
Eurofarma Laboratorios S.A.
Alopecia
03/24
03/24
ChiCTR2300077296: Efficacy of 2% concentration of topical minoxidil tincture combined with micronedles in the treatment of androgenic alopecia areata (AGA) in Chinese adult women: a single-center, randomized, open-controlled clinical trial

Not yet recruiting
3
234
 
2% minoxidil tincture twice daily, dosage of 1ml each time for 24 weeks; 2% minoxidil tincture 1ml bid combined with microneedle q2w for 24weeks; 2% minoxidil tincture 1ml bid combined with microneedle q4w for 24weeks
Dermatology Hospital of Southern Medical University; Dermatology Hospital of Southern Medical University, Clinical Research Project of Shanxi Zhendong Pharmaceutical Co., LTD. (ZD-ZY-HX-20221012001)
Androgenic alopecia
 
 
NCT06501924: Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Not yet recruiting
3
516
NA
DA-005, Daniel Alain Botanical Supplement Treatment for Hair Loss, Topical minoxidil 5%, DA-002, Placebo Oral Tablet, Placebo Topical Solution
Applied Biology, Inc., Follea International Limited, Daniel Alain, Inc.
Androgenetic Alopecia, Female Pattern Baldness, Male Pattern Baldness
10/25
12/25
NCT04594018: Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

Recruiting
3
190
RoW
Finlândia Association + finasteride placebo, Minoxidil + finasteride
EMS
Androgenetic Alopecia
04/25
09/25
NCT04481412: Topical Cetirizine in Androgenetic Alopecia in Females

Completed
2/3
66
RoW
Topical cetirizine, Cetirizine 1%, Placebo, 96% ethanol, Topical minoxidil, Minoxidil 5%
Cairo University
Androgenetic Alopecia
11/21
11/21
NCT05990400: Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia

Recruiting
2/3
40
RoW
Finasteride, Minoxidil
Indonesia University
Androgenetic Alopecia
10/23
12/23
2006-005745-11: Efficacité du minoxidil chez les enfants atteints du syndrome de Williams et Beuren : un essai clinique randomisé

Ongoing
2
11
Europe
LONOTEN, LONOTEN
Hospices Civils de Lyon
Williams syndrome
 
 
2017-000613-22: A 16 week study to assess the effectiveness of two minoxidil formulations in humans with hereditary hair loss

Ongoing
2
140
Europe
5% Minoxidil Topical Gel, 5% Minoxidil Topical Foam, F13496-121, Gel, Cutaneous foam, Regaine 5 % Schaum zur Anwendung auf der Kopfhaut
Johnson & Johnson Consumer Inc, Johnson & Johnson Consumer Inc
Alopecia Androgentica, Hereditary hair loss, Body processes [G] - Physiological processes [G07]
 
 
2019-000950-78: Multi center clinical study to evaluate the safety and efficacy of CB-03-01 for the treatment of female pattern hair loss, versus Minoxidil and placebo at different dosage of CB-03-01

Not yet recruiting
2
280
Europe
Cortexolone 17α-propionate solution 5%, Cortexolone 17α-propionate solution 7.5%, CB-03-01 solution 5%, CB-03-01 solution 7.5%, Cutaneous solution, Regaine® Frauen
Cassiopea S.p.A., Cassiopea S.p.A.
Female Androgenic Alopecia (AGA) is scalp hair loss that occurs due to an underlying susceptibility of hair follicles to androgenic miniaturization. In the hair follicle, testosterone is converted by 5α-reductase into 5α-dihydrotestosterone (DHT). The DHT level is increased in the balding scalp and may be the more relevant androgen for AGA pathogenesis. Thus, blocking or inhibiting the effect of DHT with the local application of Anti-androgens may be an effective treatment for AGA., Female Androgenetic alopecia (AGA) is scalp hair loss which is due to a change in hormon concentrations which results in reduced hair growth and hair loss., Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
NCT03852992: Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

Withdrawn
2
48
US
Post-Laser Minoxidil 2%, Rogaine, At-Home Minoxidil 5%, Laser, Post-laser 5mg minoxidil, Post-laser 10mg minoxidil, Post-laser 20mg minoxidil
University of Minnesota
Male Pattern Hair Loss, Androgenetic Alopecia, Male Pattern Baldness
07/23
07/23
NCT05272462: Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

Recruiting
2
34
US
Minoxidil, Rogaine
Loyola University, Cures Within Reach, Medical University of South Carolina
Ovarian Cancer
12/24
12/24
NCT06826001: Various Procedural Treatment Options for Androgenetic Alopecia

Not yet recruiting
2
190
RoW
topical finasteride, Topical minoxidil
Sheikh Zayed Medical College
Androgenetic Alopecia
07/25
07/25
NCT05778825: A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Recruiting
2
60
US
Oral Minoxidil, Placebo
Memorial Sloan Kettering Cancer Center
Survivors of Childhood Cancer, Alopecia
03/26
03/26
NCT06333600: Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss

Recruiting
1/2
45
RoW
Topical minoxidil, Rogaine, Topical Vitamin D, Calcipotriol, Saline spray, saline
Sohag University
Dermatology, Female Pattern Baldness
04/24
05/24
NCT06108193: Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris

Recruiting
1/2
26
RoW
topical minoxidil in Acne Vulgaris
Chang Gung Memorial Hospital
Acne Vulgaris
12/23
12/23
NCT05636904: Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men

Completed
1/2
120
RoW
prostaglandin F2a analogue in vehicle solution high dose, DLQ01 high dose, prostaglandin F2a analogue in vehicle solution low dose, DLQ01 low dose, active ingredient-free vehicle solution to DLQ01, DLQ01 vehicle, Minoxidil 5% Topical Solution, Regaine®
Dermaliq Therapeutics, Inc.
Androgenetic Alopecia
03/24
03/24
NCT06527729: A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata

Completed
1
28
RoW
sildenafil-loaded liposomes, minoxidil gel
Assiut University
Alopecia Areata
06/22
10/22
NCT05790941: Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation

Recruiting
1
12
US
Latanoprost and Minoxidil
Aneira Pharma, Inc.
Hypotrichosis
06/23
06/23
NCT05864885: Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia

Not yet recruiting
1
14
NA
Minoxidil, Latanoprost
Aneira Pharma, Inc., DataPharm Australia, CMAX Clinical Research, Agilex Australia
Androgenetic Alopecia
07/23
07/23
NCT03831334: Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

Active, not recruiting
1
14
US
oral minoxidil
Northwestern University
Permanent Chemotherapy-induced Alopecia
06/24
06/24
NCT06015516: Bioavailability Clinical Trial of Oral Minoxidil 1 mg

Completed
1
14
Europe
Minoxidil Tablets, Minoxidil topical solution 20 mg/ml
Industrial Farmacéutica Cantabria, S.A.
Healthy
03/24
03/24
NCT05417308: Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Recruiting
1
50
US
Minoxidil, Alostil, Loniten, Rogaine, U 10858, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Ohio State University Comprehensive Cancer Center
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Endocrine Therapy-Induced Alopecia, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
12/25
12/25
ACTRN12623000356662: The effect of sublingual minoxidil and oral dutasteride in trans people with androgenic alopecia while on testosterone

Active, not recruiting
1
32
 
The University of Melbourne, The University of Melbourne
Androgenic alopecia
 
 
NCT06679556: Phase 1 Pharmacokinetic Study of Minoxidil SL Tablets

Completed
1
12
RoW
Strength A Sublingual Minoxidil, Strength B Sublingual Minoxidil
Samson Clinical Operations Pty Ltd
Pharmacokinetic
12/24
12/24
ChiCTR1900021107: Combined treatment with topical minoxidil and nano-microneedle-assisted fibroblast growth factor in male androgenetic alopecia

Completed
N/A
40
 
nano-microneedle combined with saline ;topical 5% minoxidil ;nano-microneedle combined with fibroblast growth factor ;combined treatment with topical minoxidil and nano-microneedle-assisted fibroblast growth factor
First Hospital of China Medical University; First Hospital of China Medical University, International Science and Technology Cooperation Project Cooperative Study on the Mechanism of Dot Laser Combined with KGF-2 Promoting Hair Growth
male androgenic alopecia
 
 
ChiCTR2000030161: Treatment of androgenic alopecia in males with autologous concentrate growth factor combined with minoxidil: a randomized self-controlled trial

Completed
N/A
16
 
local injection of autologous concentrate growth factor combined with minoxidil for external use in half head
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine; Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, funds raised independently
Androgenic alopecia in males
 
 
ChiCTR1900022122: Efficacy and safety of 2% minoxidil combined with microneedling in the treatment of female pattern hair loss: a randomized controlled trial

Recruiting
N/A
338
 
Topical 2% minoxidil combined with microneedling ;Topical 2% minoxidil
Huashan Hospital, Fudan University; Huashan Hospital, Fudan University, Huashan Hospital, Fudan University
Female pattern hair loss
 
 
ChiCTR1900023751: Efficacy and safety of 5% minoxidil combined with microneedling in the treatment of alopecia areata of stable period: a randomized controlled trial

Recruiting
N/A
100
 
Left scalp: 5% minoxidil combined with microneedling; Right scalp: 5% minoxidil ;Right scalp: 5% minoxidil combined with microneedling; Left scalp: 5% minoxidil
Huashan Hospital, Fudan University; Huashan Hospital, Fudan University, Huashan Hospital, Fudan University
Alopecia areata
 
 
ChiCTR2000038833: Clinical trial of effect on androgenic alopecia treated with decoction of Garden Balsam and Platycladus orientalis leaves

Recruiting
N/A
180
 
Decoction of Garden Balsam and Platycladus orientalis leaves (3-5ml each time), evenly spread on the head, and massage with hands for 3-5 minutes, twice a day. ;Decoction of Garden Balsam and Platycladus orientalis leaves (3-5ml each time), evenly spread on the head, and massage with hands for 3-5 minutes, twice a day.Oral decoction of Garden Balsam and Platycladus orientalis leaves (100ml each time), half an hour after meal, twice a day. ;Apply 5% minoxidil tincture (National drug approval number: h20010714), 1ml each time (about 7 sprays) on head, and massage with hands for 3-5 minutes, twice a day.
Jiaxing Hospital of Chinese Medicine; Jiaxing Hospital of Chinese Medicine, Project of science and technology of Chinese medicine in Zhejiang Province
Androgenic alopecia
 
 
ChiCTR1800019282: A randomized, open label, parallel controlled trial for botulinum toxin A injection combined with minoxidil in the treatment of androgenic alopecia

Not yet recruiting
N/A
75
 
Minoxidil group for external use; botulinum toxin A injection group ;Topical minoxidil combined with injection of botulinum toxin type A
Shanghai Tongji Hospital; Shanghai Tongji Hospital, The project of self selection
Androgenetic alopecia
 
 
ChiCTR2100044015: Comparative study on treatment methods of female pattern hair loss

Completed
N/A
135
 
Minoxidil solution ;Minoxidil solution and spironolactone ;Minoxidil and laser hair cap ;Minoxidil and microneedle ;YuFa and microneedle
Beijing Friendship Hospital affiliated to Capital Medical University; Beijing Friendship Hospital affiliated to Capital Medical University, self-financing
female pattern hair loss
 
 
ChiCTR2000029451: A randomized, open label, parallel-controlled trial for CO2 fraction laser combined with topical minoxidil in the treatment of androgenic alopecia

Not yet recruiting
N/A
60
 
The hair loss area was treated by Co2 dot-matrix laser irradiation once, pulse energy 10 MJ, dot-matrix coverage 6.3% . After treatment, the hair was iced for 15 min, local water was avoided within 12 H, and antibiotic ointment was applied, once a month for 12 months. 5% MINOXIDIL was given oral ;The hair loss area was treated by Co2 dot-matrix laser irradiation once, pulse energy 10 MJ, dot-matrix coverage 6.3% . After treatment, the hair was iced for 15 min, local water was avoided within 12 H, and antibiotic ointment was applied, once a month for 12 months. ;Local hair loss area for external use Minoxidil, once a day, for a year.
Shanghai tongji hospital; Shanghai Tongji hospital, none
androgenic alopecia
 
 
ChiCTR2000032671: A prospective randomized controlled study on the treatment of Female Androgenic Alopecia with cell-free fat extract

Not yet recruiting
N/A
24
 
Cell-free extract injection ;Minoxidil for external use
The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine; Affiliated Hangzhou First people's Hospital, Zhejiang University School of Medicine, Horizontal project of the Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Female Androgenic Alopecia
 
 
ChiCTR2000033207: Randomized, open, parallel controlled clinical study of Haiai Decoction combined with oral administration of finasteride for male androgenic alopecia

Not yet recruiting
N/A
90
 
Oral Finasteride 1mg / D + external water shampoo ;Oral Finasteride 1mg / D + Haiai Decoction for external use ;Oral Finasteride 1mg / D + topical 5% Minoxidil
Shanghai Tongji Hospital; Shanghai Tongji Hospital, nothing
androgenic alopecia
 
 
NCT05369481: Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia

Recruiting
N/A
50
RoW
Sildenafil 2%, Local Scalp Injection, Minoxidil 5 %
Mohammed Abd El Mawgoud Amer
Androgenic Alopecia
08/22
09/22
NCT05435625: Fractional Laser Versus Radiofrequency in Androgenetic Alopecia

Recruiting
N/A
30
RoW
FCO2, FRF
Kasr El Aini Hospital
Androgenic Alopecia
09/22
12/22
ChiCTR2100051480: Clinical trial to evaluate the safety and efficacy of ablative fractional CO2 laser in the treatment of mild to moderate alopecia areata in Chinese adults

Recruiting
N/A
30
 
minoxidil solution treatment of treatment of alopecia areata ;ablative fractional CO2 laser treatment of alopecia areata
Dermatology Hospital of Southern Medical University; Dermatology Hospital of Southern Medical University, self-raised
alopecia areata
 
 
NCT05681897: Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia

Recruiting
N/A
30
RoW
Platelet-Rich Plasma Injections (PRP) on the Scalp, Regrou Forte (5% Minoxidil solution)
Indonesia University
Alopecia, Androgenetic
02/23
02/23
ChiCTR2000034976: A randomized, open label, placebo-controlled trial for platelet-rich plasma(PRP) combined with topical 5% minoxidil in the treatment of male androgenic alopecia

Not yet recruiting
N/A
30
 
5% minoxidil solution, 1ml for external application each time,twice a day for 6 months. On this basis, it is combined with local injection of PRP, 0.15 ml/cm2 each time, monthly, 3 times totally. ;5% minoxidil solution, 1ml for external application each time, twice a day for 6 months. On this basis, it is combined with local injection of 0.9% normal saline, 0.15 ml/cm2 each time, monthly, 3 times totally.
Shanghai Tongji Hospital; Shanghai Tongji hospital, None
Androgenic alopecia
 
 
ChiCTR2200064992: A prospective randomized controlled study on the treatment of female pattern hair loss with cell-free fat extract

Not yet recruiting
N/A
24
 
Cell-free extract injection ;5% Minoxidil for external use
Hangzhou First People's Hospital; Hangzhou First People's Hospital, Shanghai Samet Cell Technology Co. LTD
female pattern hair loss
 
 
NCT06218498: Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia

Recruiting
N/A
135
RoW
ablative fractional 2940-nm Er: YAG laser, non-ablative fractional 1565nm, 5% Minoxidil
Second Affiliated Hospital, School of Medicine, Zhejiang University
Androgenetic Alopecia
06/24
12/24
NCT06066827: Hair Regeneration in Androgenetic Alopecia

Active, not recruiting
N/A
60
RoW
Minoxidil Topical, Secretome from adipose-derived stem cells, Combination of minoxidil and secretome from adipose-derived stem cells
Dr. dr. Lili Legiawati, SpKK(K), Ministry of Education, Culture, Research, and Technology, Republic of Indonesia, PT. Kimia Farma (Persero) Tbk
Androgenetic Alopecia
11/23
11/23
NCT06218394: Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia

Recruiting
N/A
135
RoW
microneedling, Autologous Concentrated Growth Factor, 5% minoxidil
Second Affiliated Hospital, School of Medicine, Zhejiang University
Androgenetic Alopecia
09/24
12/24
NCT05827991: A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia

Recruiting
N/A
75
RoW
1565nm Non-ablative Fractional Laser, 5% minoxidil external use, 1565nm Non-ablative Fractional Laser combined with 5% minoxidil
Xijing Hospital
Androgenic Alopecia
12/23
12/23
NCT05587257: Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata

Not yet recruiting
N/A
60
NA
Fractional CO2 laser, Drug, Derma pen, Niosome minoxidil, Minoxidil Topical Spray
Assiut University
Alopecia Areata
01/24
02/24
NCT06552039: Proof-of-Science, Prospective, Interventional, Three-arm, Double-Blind, Randomized, Safety and Efficacy Real World Evidence Study.

Not yet recruiting
N/A
99
NA
Polyherbal Hair Oil, Minoxidil Herbal Hair Oil + Minoxidil 5 (%) Hair Serum, Minoxidil Hair Serum
NovoBliss Research Pvt Ltd
Hair Fall and Pre-mature Graying
12/24
12/24
NCT06556056: An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)

Not yet recruiting
N/A
54
NA
SesZen-Bio Serum, Minoxidil hair serum (1%), Placebo
NovoBliss Research Pvt Ltd, Zywie Ventures Privated Ltd
Androgenic Alopecia
03/25
03/25
ChiCTR2300077392: Clinical efficacy and safety of microneedles with nitric oxide source complex solution in the treatment of non-menopausal female pattern hair loss

Completed
N/A
120
 
microneedles combined with nitric oxide source complex solution; simple topical minoxidil solution; microneedles combined with minoxidil solution
Beijing Friendship Hospital, Capital Medical University; Beijing Friendship Hospital, Capital Medical University, self-financed
female pattern hair loss
 
 
ChiCTR2400085181: Clinical Efficacy and Safety Study of Recombinant Humanized Collagen XVII in the Treatment of Androgenetic Alopecia

Not yet recruiting
N/A
110
 
Apply 0.9% sodium chloride solution topically once daily for a total of 24 weeks.; For women, apply 1 ml of 5% Minoxidil Tincture topically once daily for a total of 24 weeks; for men, apply 1 ml of 5% Minoxidil Tincture topically twice daily for a total of 24 weeks; Apply one vial of recombinant type XVII collagen lyophilized fiber topically once daily for a total of 24 weeks; Perform microneedling combined with topical application of one vial of recombinant humanized type XVII collagen lyophilized fiber once every two weeks for a total of 24 weeks.
Beijing Friendship Hospital, Capital Medical University; Beijing Friendship Hospital, Capital Medical University, self-financed
Androgenetic Alopecia
 
 
ChiCTR2300071986: A single-center, randomized, single-blind, minoxidil controlled clinical efficacy study of concentrated nano fat in the treatment of androgenetic alopecia

Not yet recruiting
N/A
98
 
nano-fat treatment ;minoxidil treatment
The first affiliated hospital of Jinan University; The first affiliated hospital of Jinan University, NA
Androgenetic alopecia
 
 
ChiCTR2500099246: Efficacy and safety of magnesium alloy-based long-acting hydrogen-releasing ointment in the treatment of male pattern androgenic alopecia

Not yet recruiting
N/A
10
 
Participants applied 5% minoxidil tincture spray twice daily, morning and evening, administering the solution evenly across the observed area.; Apply the ointment twice daily, morning and evening, using 2 grams of Ointment A and 2 grams of Ointment B. Ensure thorough mixing before application and spread evenly over the test area.
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Ninth People's Hospital, Self-funded research project
Male androgen alopecia
 
 
ChiCTR2500096253: Effect of 5% minoxidil foam in combination with spironolactone in the treatment of female pattern hair loss

Not yet recruiting
N/A
80
 
NA; NA
Xiangya Hospital, Central South University; Xiangya Hospital Central South University, Researcher Project funding
female pattern hair loss
 
 
ChiCTR2300070840: Efficacy and safety of carbon dioxide fractional laser combined with minoxidil in the treatment of androgenetic alopecia

Not yet recruiting
N/A
178
 
Minoxidil combined with carbon dioxide fractional laser ;Minoxidil
Tongji Hospital Affiliated to Tongji University; Tongji Hospital Affiliated to Tongji University, Shanghai Municipal Health Commission
androgenetic alopecia
 
 
ChiCTR2400086751: A preliminary study on the characterization of hair microscopic analysis and prevention and treatment strategies after chemotherapy.

Not yet recruiting
N/A
100
 
Topical application of 5% minoxidil 1 ml topically once a day, plus 20 minutes of light once every two days using a low level laser cap.; Topical application of 5% minoxidil 1 ml topically once a day; Topical application of placebo 1 ml topically once a day; No treatment
Affiliated Hospital of Yanbian University; Affiliated Hospital of Yanbian University, Entrusted projects by enterprises and public institutions
Chemotherapy-induced alopecia
 
 
ChiCTR2300078123: Randomized controlled study of scalp acupoint catgut embedding combined with topical 5 % minoxidil tincture to improve male androgenetic alopecia

Recruiting
N/A
70
 
Basic treatment: According to the 2019 "Guidelines for the diagnosis and treatment of androgenetic alopecia in China", both groups of subjects were treated with 5 % minoxidil tincture for external use, once in the morning and once in the evening, 1ml each time, sprayed on the hair loss area on the top of the head. Embedding therapy: The subjects were placed in a prone position, and the top of the head was fully exposed. The target area was marked with a semi-permanent ornamentation method. After surgical disinfection in the circumferential area with a radius of 4cm centered on the marked point, 2 % lidocaine anesthesia was performed in the circumferential area with the marked point as the center and a radius of 2cm. The 1cm medical absorbable polyglycolic acid surgical suture was placed at the front end of the disposable embedding needle using the tweezers in the disposable embedding auxiliary package. The needle tip reached the subgaleal space at a depth of about 2-4mm. After the subjects had a sense of acid bloating, the needle core was pushed while the needle tube was withdrawn, and the thread body was placed in the space under the cap-like aponeurosis. The needle tip direction points outward from the anesthesia area to the eight directions of the circumference, east, west, south, north, southeast, southwest, northeast, and northwest. After the eight parts are treated, they are disinfected again.; Basic treatment: According to the 2019 "Guidelines for the diagnosis and treatment of androgenetic alopecia in China", both groups of subjects were treated with 5 % minoxidil tincture for external use, once in the morning and once in the evening, 1ml each time, sprayed on the hair loss area on the top of the head. Catgut embedding therapy: acupoint catgut embedding needle acupuncture treatment, disposable catgut embedding needle is not placed in the medical absorbable polyglycolic acid surgical suture, the rest of the operation method is the same as the acupoint catgut embedding group.
China-Japan Friendship Hospital; China-Japan Friendship Hospital, 1. National High Level Hospital Clinical Research Funding; 2. Elite Medical Professionals Project of China-Japan Friendship Hospital (NO.ZRJY2023-GG16)
androgenetic alopecia
 
 
ChiCTR2400088536: Clinical study of new polymer polylactic acid microneedle combined with 5% minoxidil application for the treatment of male androgenetic alopecia

Not yet recruiting
N/A
30
 
All study participants were sprayed with 1 ml of Minoxidil 5% application each time on the scalp area starting on day 1, applied evenly to all scalp areas, and the scalp was gently massaged with the hands until fully absorbed, ensuring that the scalp was completely dry before application. The medication is administered twice daily (morning and evening, bid). In addition, after the weekly medication, the patient should return to the hospital to receive the new polymer PLA micro-needling treatment, which is operated by the same medical team members who have been professionally trained. The method of operation: the patient maintains a comfortable seated position, and the right side of the scalp is fully exposed with the midline of the head as the boundary, the applicator will first disinfect the right side of the scalp with 75% alcohol twice, and then, when the alcohol is dry, the applicator will place strips in a row to disinfect the right scalp area, and then, the applicator will place the strips in a row. After the alcohol is dry in the scalp area, the needle applicator will gently prick the PLA microneedles arranged in strips to cover the scalp area of the hair seams once a week (qw) for 24 consecutive weeks of treatment.
China-Japan Friendship Hospital; China-Japan Friendship Hospital, Zhongshan Wanhan Pharmaceutical Co.
androgenetic alopecia
 
 
ACTRN12607000027415: Investigation into the treatment of Female Pattern Hair Loss

Not yet recruiting
N/A
150
 
Prof Rodney Sinclair, Head of Department of Dermatology, St Vincent's Hospital, Melbourne, NHMRC
Female Pattern Hair Loss
 
 

Download Options